Central line-associated bloodstream infections (CLABSIs) and ventilatorassociated pneumonias (VAPs) result in significant morbidity 1, 2 and mortality 3, 4 among hospitalized children. Catheterassociated urinary tract infections (CAUTIs) have not been as extensively studied in pediatric populations, but are associated with poor outcomes among adults. 5, 6 Health care-associated infections (HAIs) result in protracted hospital stays, 1 increased cost, [7] [8] [9] and prolonged need for mechanical ventilation. 3 They are also associated with poor neurodevelopmental outcomes, particularly for extremely low birth weight infants. 2 Despite their significant negative sequelae, HAIs are common among children in ICUs and have been reported to occur in 9% to 21% of critically ill children. 1, [10] [11] [12] Further, it is estimated that a CLABSI results in additional hospital costs ranging from $16 000 12 to $39 000. 13 HAIs continue to be responsible for a substantial burden of preventable adverse events among hospitalized children and have been highlighted by national quality improvement organizations as targets for improvement. [14] [15] [16] [17] Yet there remain limited national data on HAI incidence rates in neonatal and pediatric populations. We examined trends in CLABSI, CAUTI, and VAP incidence rates between 2007 and 2012 based on standardized surveillance data from PICUs and NICUs in the United States.
METHODS

Study Design and Population
Our study population included NICUs and PICUs located in nonfederal acutecare hospitals reporting data to the Centers for Disease Control and Prevention' s (CDC) National Healthcare Safety Network (NHSN) between January 1, 2007, and September 30, 2012 . The following types of hospitals were excluded: critical access hospitals, long-term care hospitals, and cancer hospitals. The hospitals in this study were a subset of hospitals participating in the Preventing Avoidable Infectious Complications by Avoiding Payment (PAICAP) study to examine the impact of national payment policies on HAI rates in the United States. 18 Hospitals were included in this study if they reported monthly data on CLABSI or VAP in NICUs, or CLABSI, VAP, or CAUTI in PICUs. We excluded pediatric stepdown units and pediatric cardiac ICUs due to low numbers of these unit types. CAUTI in the NICU was reported infrequently during this time period and thus is not reported in this study.
We used a time series design to evaluate trends in HAI rates between January 2007 and September 2012 for neonatal (NICU) and pediatric (PICU) populations. In each of these populations, we estimated rates of CLABSI per 1000 central-line days, CAUTI per 1000 urinary catheter days, and VAP per 1000 ventilator days by using standardized surveillance definitions from the CDC NHSN. 19 NHSN definitions were applied by infection control personnel before reporting data to the CDC and were based on each center' s interpretation of NHSN' s definitions. Because HAIs may occur more frequently among low birth weight infants, 20 we adjusted models in the NICU population for birth weight, as reported to NHSN. For descriptive purposes, we obtained information on hospital location, size, ownership, teaching status, and designation as a freestanding children' s hospital from the 2009 American Hospital Association Annual Survey. 21 This study was approved by the institutional review board of Harvard Pilgrim Health Care.
Data Analysis
Descriptive statistics were generated to describe our population of hospitals. We estimated incidence rate ratios (IRRs) describing the relative change in HAI rates per quarter by using negative binomial mixed effects models with random slopes and intercepts for hospital. We aggregated rates at the quarterly rather than monthly level to increase stability of IRR estimates. Separate models were created for CLABSI, CAUTI, and VAP rates for each setting type (neonatal, pediatric) as appropriate. Birth weight (#1500 g; 1501-2500 g; .2500 g) was included as a covariate in neonatal models. We included interaction terms (birth weight 3 time) to further explore whether there were differences in HAI rates over time by birth weight category (#1500 g; 1501-2500 g; .2500 g). In a sensitivity analysis to determine if the 2008 CLABSI definition change (ie, requiring 2 blood cultures for common skin contaminants) affected infection rates for neonates, we reran similar mixed-effects models with a restricted study population to the 2008 to 2012 time period. 22 We also conducted a separate sensitivity analysis by using similar negative binomial models to explore whether our findings may have been influenced by the timing of initiation of NHSN reporting by restricting our analyses to hospitals consistently reporting throughout our study period (ie, reporting in at the beginning of the study period in January 2007 and also at the end of our study period in September 2012). We considered P , .05 to be statistically significant. Analyses were completed by using SAS version 9.3 (SAS Institute, Inc, Cary, NC).
RESULTS
Study Population
Our study included a total 174 participating US hospitals, of which 173 reported data for NICUs and 64 reported data for PICUs. ICUs varied in size, with NICUs in our sample having a median of 22 Table 3 ). In addition, VAP incidence rates decreased from 1.6 to 0.6 per 1000 ventilator days (IRR 0.97, 95% CI 0.93-0.99 per quarter) among neonates during the same period (Fig 1, Table 2 ). Infants with birth weights #1500 g were more likely to develop CLABSI (IRR 2.24, 95% CI 1.96-2.57) and VAP (IRR 3.48, 95% CI 2.11-5.74) when compared with infants with birth weights .2500 g ( Table 2 ). We did not find evidence to suggest that declines in CLABSI or VAP differed over time across birth weight categories (P value for interaction term for CLABSI = .10; for VAP = .45).
Among hospitalized children in PICUs, incidence rates of CLABSI decreased from 4.7 to 1.0 per 1000 line days (IRR 0.96, 95% CI 0.94-0.98 per quarter) and VAP decreased from 1.9 to 0.7 per 1000 ventilator days (IRR 0.95 per quarter, 95% CI 0.92-0.98), whereas CAUTI incidence rates did not change significantly (Fig 2,  Table 2 ). These findings were similar for hospitals that consistently reported throughout the entire study period, as shown in Supplemental Table 4 .
DISCUSSION
Among a large sample of hospitals in the United States caring for critically ill neonates and children, we found substantial declines in several HAI incidence rates between January 2007 and September 2012. In addition to improving important patient outcomes, we estimate the reduction in CLABSI among hospitals in our sample resulted in savings of $131 million (∼$61 million in NICUs; ∼$70 million for PICUs) 12, 13 to these hospitals during our study period. For critically ill neonates, incidence rates of CLABSI decreased by 4% per quarter (61% decline during the study period), whereas incidence rates of VAP declined by 3% per quarter (50% decline during the study period), representing sustained improvement for this vulnerable population. These findings are similar to reported decreases in CLABSI for neonates in state [23] [24] [25] [26] and multistate collaborations. 27 Similar to previous studies, 1, 20 we found that very low birth weight (VLBW) infants were more likely to have CLABSI or VAP than normal birth weight infants. When compared with normal birth weight infants, VLBW infants were .2 times more likely to have CLABSI and nearly 3.5 times more likely to develop VAP. This may be due to decreased innate and adaptive immunity of VLBW infants 28 and higher rates of device utilization, the combination of which increases the risk of HAIs substantially. Despite these challenges, VLBW infants have been the subject of large-scale quality improvement efforts to reduce CLABSI over the past decade, and this likely contributes to the substantial reductions seen. For example, the Vermont Oxford Network, a collaboration that now includes more than 900 hospitals, uses "Potentially Better Practices" (PBPs) as a bundle of possible interventions for NICUs to adapt to the unique needs and culture of their unit. Such PBPs are part of a broadquality effort that includes data feedback, quality improvement training, and site visits. Examples of elements of PBPs used by participating centers include promoting hand washing, reducing hyperalimentation (as a means to reduce device utilization), implementing protocols for skin care of extremely low birth weight infants to reduce skin breakdown, reducing laboratory testing and venipunctures, and establishing protocols for line-care maintenance and access. The organizers note that PBPs are used differently in different units; therefore, they hypothesize that reductions in HAI seen as part of their collaborative are as much a part of local multidisciplinary N/A, not applicable. a Interaction terms for time 3 birth weight were not significant for the CLABSI (P = .10) or VAP (P = .45) models. b IRR is interpreted as percentage change per quarter (eg, IRR of 0.96 is a decrease of 4% per quarter). c IRR for birth weight categories are interpreted similar to odds ratios (e.g. IRR of 1.12 of 1500-2500 group reflects that this group has a 12% increased odds of CLABSI when compared to the reference group of .2500 g).
efforts focused on unit change to improve clinical outcomes as it is on the individual elements of PBPs. 29 Among critically ill children in PICU settings between January 2007 and September 2012, we found that incidence rates of CLABSI decreased by 4% per quarter (61% decline during the study period), and incidence of VAP decreased by 5% per quarter (76% during the study period). These findings are similar to a recent study describing decreasing trends among HAIs in adults 18 and in a multistate PICU collaboration, 30 and may be the result of a national focus on reducing CLABSI by government agencies 31 and quality improvement organizations. 14 In our study, we found that CAUTI incidence rates remained unchanged throughout the study period; however, several changes to the CAUTI surveillance definition over the past year may have precluded our ability to assess whether meaningful improvements have occurred. Furthermore, CAUTI has not received the same level of national attention among pediatric quality improvement networks as CLABSI or VAP. However, it is important to note that when improvement efforts have focused on eliminating CAUTI in critically ill children, they have yielded decreases in this important HAI. 32 Monitoring recent trends in HAIs among children is particularly relevant as national policies to prevent HAIs relevant to these populations are enacted. In 2010, the Patient Protection and Affordable Care Act mandated that Medicaid, the payer for more than one-third of US children, 33 begin penalizing hospitals for certain HAIs beginning on July 1, 2012. 34 The policy, similar to the one enacted by Medicare in 2008, 35 aims to motivate hospitals through financial incentives. In the past, hospitals may have received additional payment for care associated with HAIs. The policies enacted by Medicaid and Medicare aim to eliminate these perverse financial incentives, in an attempt to reduce rates of HAIs and other preventable complications. As policymakers continue their efforts to align quality and payment through the Medicaid program, we will need to carefully consider the potential financial impact on hospitals that care for high-risk neonates and children and be mindful that rates of HAI for children were decreasing before policy implementation.
Our study has several potential limitations. First, although data among our cohort were gathered from a large group of US hospitals in 39 states that serve neonatal and pediatric patients, it did not include all US hospitals, possibly limiting its generalizability. Hospitals included in our study either may have had higher initial rates of HAIs or may have had more focused efforts on HAI reduction than other US hospitals. Additionally, quality improvement approaches may have differed between the hospitals included in this study versus those in the general population of US hospitals. There also may be regional differences in mandated hospital HAI reporting that may affect our data. Second, despite the use of rigorous clinical data and standardized HAI definitions, inter-and intrahospital variability in implementation of NHSN surveillance definitions may still occur. 36 Nonetheless, NHSN surveillance data are currently the best available data source for evaluating rates of device-associated infections in the United States, in comparison with alternative data sources, such as hospital billing data. 37, 38 Third, the number of hospitals reporting during our study period increased over time, which may affect the interpretation of our findings if the composition of these institutions differed in characteristics that affect rates of HAIs. However, when we restricted the analysis to hospitals that consistently reported during the study period, our findings were similar. Although the overall burden of HAIs has dramatically declined, we were likely underpowered to detect differences in rates of decline by birth weight category (ie, effect modification). Next, some have expressed concern regarding the reliability of the NHSN VAP definition, especially among neonates, which could affect our results. 39, 40 Finally, pediatric stepdown units and pediatric cardiac ICUs were excluded from our study because of small numbers, limiting our ability to generalize findings to these settings.
CONCLUSIONS
Over the past several years, US hospitals made substantial improvements in preventing harm to hospitalized neonates and children by reducing HAIs. HAI incidence rates fell dramatically among neonates of all birth weights and among children, reducing their risk of morbidity and mortality. Eliminating HAIs must remain a prominent quality improvement goal to protect our most vulnerable patients.
